Related Experiment Video
Updated: Jul 26, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Triclabendazole in the treatment of human fascioliasis: a community-based study
H el-Morshedy1, A Farghaly, S Sharaf
1Department of Tropical Health, University of Alexandria, Egypt.
Abstract:
The efficacy of triclabendazole in the treatment of chronic Fasciola infection was assessed. A total of 134 asymptomatic cases of established Fasciola infection were treated: 68 individuals received a single dose of 10 mg/kg and 66 individuals received 2 doses of 10 mg/kg on 2 consecutive days. Cure was assessed 5 weeks after treatment and 79.4% of the first group and 93.9% of the second group were cured. The drug was well tolerated; no serious side-effects were noted. One patient developed biochemical cholestasis the third day after treatment, but her enzyme profiles returned to normal after 2 months. We conclude triclabendazole is a safe and potent fasciolicidic drug.
More Related Videos
Related Concept Videos
Leishmaniasis
American Trypanosomiasis
Giardiasis
Trichomoniasis
Anthelminthic Agents
Antiprotozoal Agents

